Alexion Pharmaceuticals, Inc.
Synthesis of cerdulatinib

Last updated:

Abstract:

The present disclosure provides processes for the preparation of cerdulatinib, which is of formula I: ##STR00001## or a salt thereof. The disclosure also provides intermediates and processes for the preparation of the intermediates useful in the preparation of cerdulatinib or a salt thereof.

Status:
Grant
Type:

Utility

Filling date:

21 Oct 2020

Issue date:

24 May 2022